Davenport & Co’s Lisata Therapeutics LSTA Stock Holding History

Davenport & Co’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10	Closed	-$8.32K	–	560
2013 Q2	$8.32K	Buy	+10	New	+$8.77K	﹤0.01%	524

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deere & Company Moline, Illinois $140M AUM 16.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Davenport & Co's LSTA Position: Q3 2013 in Review

Davenport & Co sold out of Lisata Therapeutics (LSTA) in Q3 2013, closing a stake of 10 shares — an estimated $8.32K sold.

Davenport & Co first reported a position in LSTA in Q2 2013 and held it in 1 quarter. The position peaked at $8.32K in Q2 2013. 31 funds tracked by Wall St. Rank hold LSTA as of Q3 2013.

Davenport & Co reported no remaining Lisata Therapeutics position as of Q3 2013 after selling out during the quarter.
Davenport & Co sold 10 Lisata Therapeutics shares in Q3 2013, an estimated $8.32K.
Davenport & Co first reported a position in Lisata Therapeutics in Q2 2013 and held it in 1 quarter.
Davenport & Co's Lisata Therapeutics position peaked at $8.32K in Q2 2013.
31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2013.

Based on Davenport & Co's 13F filing for Q3 2013, filed 1 Nov 2013.